Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

JAMA Oncol. 2016 Apr;2(4):543-5. doi: 10.1001/jamaoncol.2015.5871.

¹ Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
² Division of Urologic Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
⁴ Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types